PDCD1 and melanoma: Of note, recent studies have highlighted the existence of the NK-DC axis in adult tumors, including melanoma, breast cancer, lung cancer, and head and neck squamous cell carcinoma15,16, and that these innate immune cells correlate with responsiveness to anti-PD-1 immunotherapy15.